MyAverix Finance
F · Healthcare
VAXART INC. DL-10 (NB11)
Biotechnology
VAXART INC. DL-10 (NB11) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $91.52M, P/E ratio is 18.00, net margin is 6.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NB11
VAXART INC. DL-10 (NB11) — FAQ
What is VAXART INC. DL-10's market cap?
VAXART INC. DL-10 (NB11) has a reported market cap of $91.52M (data as of 2026-03-30).
What is NB11's P/E ratio?
The price-to-earnings (P/E) ratio for VAXART INC. DL-10 (NB11) is 18.00 (data as of 2026-03-30).
Does VAXART INC. DL-10 pay a dividend?
Dividend yield is not available in the current snapshot for VAXART INC. DL-10 (NB11). Check the MyAverix Finance app for the latest dividend data.
What sector is VAXART INC. DL-10 in?
VAXART INC. DL-10 (NB11) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NB11 listed on?
NB11 is listed on F.
What is VAXART INC. DL-10's net margin?
VAXART INC. DL-10 (NB11) reports a net margin of 6.9% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.